GSK's experimental drug to treat chronic hepatitis B infection met the main goal in two closely watched studies, the ...
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, ...
The B-Well 1 and B-Well 2 trials evaluated the safety, efficacy, and durability of bepirovirsen in nucleos(t)ide analogue-treated participants with CHB.
The World Health Organization has issued its first-ever hepatitis B guidelines that outline how to determine who needs treatment, what medicines to use and how to monitor patients long-term. The ...
By broadening definition of success to include sustained low-level HBsAg with suppressed HBV DNA, we can recognize clinically ...
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer than six months are considered "chronic." Chronic hepatitis B (CHB) poses ...
15don MSN
Netrin-1 disrupts hepatitis B virus attachment and internalization, offering new treatment path
Hepatitis B virus (HBV) infects more than 250 million people worldwide and can lead to chronic liver disease and liver cancer. Current antiviral therapies suppress viral replication but do not ...
Vaccination against hepatitis B is a common recommendation, but what exactly is it preventing? HHS Secretary Robert F. Kennedy Jr. and his advisory group plan to meet this week to discuss and vote on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback